NCT00980434
Completed
Not Applicable
The Clinical Use of S-100B and NSE in Spinal Cord Injuries
ConditionsSpinal Cord Injury
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Spinal Cord Injury
- Sponsor
- Medical University of Vienna
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Neurological Symptoms
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The investigators are studying the clinical worth of the serum markers S-100B and NSE in patients with spinal cord injuries e.g. in patients with vertebral fractures. If there is a injury to the neuronal structures these two proteins could be secreted into the serum and add evidence to the severity of the injury.
Investigators
Eligibility Criteria
Inclusion Criteria
- •vertebral fracture
- •injuries to the vertebral spine
Exclusion Criteria
- •head trauma
- •polytrauma
Outcomes
Primary Outcomes
Neurological Symptoms
Time Frame: 2 weeks
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
S100B in Intensive Care Patients With and Without Traumatic Brain InjuryTumorBrain InjuriesTrauma InjuryCritical IllnessSurgery--ComplicationsNCT04501315University of Erlangen-Nürnberg Medical School600
Completed
Not Applicable
Neuromarker S-100B as Diagnostic ToolSpinal InjuryNCT01840397Medical University of Vienna30
Completed
Not Applicable
The Neuromarker S-100B in Patients With Different Types of Intracranial InjuryTraumatic Brain InjuryTraumaNCT01619293Medical University of Vienna1,800
Unknown
Not Applicable
Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic SclerosisSystemic SclerosisNCT00453752Medical University of Warsaw100
Unknown
Not Applicable
Detection of Peripheral Blood Biomarkers in Intermediate Phase Spinal Cord Injury: Correlation With Neurological and Functional Outcomes, and Comparison to Other Central and Peripheral Neurological Conditions.Spinal Cord InjuryNCT01516385Sheba Medical Center150